Biggest News Aggregation in the World
📰 Fda Approval News

Fda Approval News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Fda Approval. Real-time updates on events, politics, business and more.

MSNBC Katy Tur Reports September 20, 2024

States that could decide the outcome feel about both candidates. Post Debate Polling from the New York times and Sienna College has this race between Kamala Harris and Donald Trump deadlocked nationally. But its a different story when you zoom in to battleground pennsylvania. Vice president harris is up 4 points among likely voters there, albeit within the margin of error. Well dig deeper into the numbers, including why the share of voters who wanted to learn more about harris before last Weeks ...
U S Small Business City Fees Hiring Hundreds City Vibrant Police Officers

KPIX CBS Evening News With Norah ODonnell July 6, 2024

investigation. and nothing will ever stop us from keeping america secure. ♪ ♪ >> norah: political showdown. the manhattan district attorney sue is a member of congress to keep republicans from interfering in the donald trump case. a cbs news investigation, how china built its own boeing 737. >> do you feel like they stole an airliner? >> i dont feel that way, i think that is a fact. ♪ ♪ >> norah: our tax series, how you can maximize your refund in a year where many of americans...
Body Cam Video Louisville Bank Shooting Ar 15 Mass Shooting Justice Department Coming Home

X4 Pharma's XOLREMDI Capsules Gets FDA Approval To Treat WHIM Syndrome

X4 Pharmaceuticals (XFOR), focused on rare diseases of the immune system, announced Monday that the U.S. Food and Drug Administration or FDA has approved XOLREMDI (mavorixafor) capsules for use in patients 12 years of age and older with WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis).
Paula Ragan Drug Administration More Such Health News Breakthrough Therapy Designation New Drug Application Chief Executive Officer

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

What We're Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall

The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
New York United States Novo Nordisk A Senate Senate Committee Investigates Ozempic Senate Committee On Health
Source: ajmc.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science